TEVA241213C16000
- 1.44
- 0.000.00%
Teva Pharmaceutical Industries Newsroom
10 Health Care Stocks Whale Activity In Today's Session
Teva Announces New Patient Access Program With Direct Relief to Provide Access to Inhalers for Uninsured Patients
Medincell Publishes Its Consolidated Half-year Financial Results
Press Release: Medincell Publishes Its Consolidated Half-year Financial Results
Unusual Options Activity: PFE, HSY and Others Attract Market Bets, PFE V/OI Ratio Reaches 167.1
Teva Pharmaceutical to Divest Japanese Venture to JKI
Takeda Pharmaceutical: To Receive Y55B From Sale of 49% Stake in JV With Teva Pharmaceutical Industries
Teva Pharmaceutical Industries Ltd. Enters Agreement to Divest Teva-Takeda Business Venture in Japan to JKI Co., Ltd.
Teva Entered Into An Agreement With JKI Co. Established By The Fund Managed And Operated By Private Equity Firm J-Will Partners Co., Through Which JKI Will Acquire Teva-Takeda; The Agreement Is Aligned With Teva's Pivot To Growth Strategy To Focus Its...
Teva Pharmaceuticals to Sell Japan Venture Teva-Takeda to JKI Co.
Express News | Teva Pharmaceutical Industries Ltd - Expects Divestiture Completion by 1 April 2025
Teva Pharmaceutical Industries Limited (TEVA) Presents at 7th Annual Evercore ISI HealthCONx Healthcare Conference Call Transcript
Piper Sandler Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $23
Teva Pharmaceutical Says Migraine Prevention Drug Shows Efficacy in Younger Patients
Teva Shares Phase 3 SPACE Trial Results Highlighting The Efficacy And Safety Of AJOVY (Fremanezumab) In Preventing Episodic Migraine In Children And Adolescents
Teva Pharmaceutical Industries Options Spot-On: On December 3rd, 64,730 Contracts Were Traded, With 820.19K Open Interest
Teva Pharmaceutical Industries Options Spot-On: On November 29th, 141.86K Contracts Were Traded, With 674.74K Open Interest
Unusual Options Activity: AMZN, TEVA and Others Attract Market Bets, AMZN V/OI Ratio Reaches 859.4
Unusual Options Activity: TEVA, IONQ and Others Attract Market Bets, TEVA V/OI Ratio Reaches 253.5
Press Release: Medincell: Videoconference and Publication of Half-year Financial Results, Tuesday, December 10th, 2024